Public Employees Retirement Association of Colorado lowered its position in shares of Teleflex Inc. (NYSE:TFX) by 0.1% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 98,925 shares of the medical technology company’s stock after selling 102 shares during the period. Public Employees Retirement Association of Colorado owned 0.23% of Teleflex worth $17,540,000 as of its most recent filing with the SEC.

A number of other large investors also recently made changes to their positions in the stock. Huntington National Bank raised its stake in shares of Teleflex by 6.5% in the second quarter. Huntington National Bank now owns 820 shares of the medical technology company’s stock worth $145,000 after buying an additional 50 shares during the last quarter. Checchi Capital Advisers LLC raised its stake in shares of Teleflex by 0.8% in the second quarter. Checchi Capital Advisers LLC now owns 837 shares of the medical technology company’s stock worth $148,000 after buying an additional 7 shares during the last quarter. Capital Fund Management S.A. bought a new stake in shares of Teleflex during the second quarter worth $227,000. Gateway Investment Advisers LLC bought a new stake in shares of Teleflex during the second quarter worth $238,000. Finally, BlueMountain Capital Management LLC bought a new stake in shares of Teleflex during the first quarter worth $224,000. Institutional investors own 93.77% of the company’s stock.

Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

Teleflex Inc. (NYSE:TFX) traded up 0.21% on Wednesday, hitting $165.14. 83,918 shares of the company traded hands. The firm has a market capitalization of $7.27 billion, a P/E ratio of 29.31 and a beta of 0.83. Teleflex Inc. has a 12 month low of $123.79 and a 12 month high of $188.79. The stock’s 50-day moving average is $175.98 and its 200 day moving average is $170.48.

Teleflex (NYSE:TFX) last released its quarterly earnings results on Thursday, July 28th. The medical technology company reported $1.89 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.74 by $0.15. Teleflex had a return on equity of 15.59% and a net margin of 14.89%. The business earned $473.60 million during the quarter, compared to analyst estimates of $468.40 million. During the same quarter last year, the company posted $1.42 EPS. Teleflex’s revenue for the quarter was up 4.8% on a year-over-year basis. Equities analysts forecast that Teleflex Inc. will post $7.33 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which was paid on Thursday, September 15th. Investors of record on Monday, August 15th were given a $0.34 dividend. The ex-dividend date of this dividend was Thursday, August 11th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.83%. Teleflex’s dividend payout ratio (DPR) is 24.11%.

TFX has been the subject of several recent research reports. Leerink Swann boosted their price target on shares of Teleflex from $183.00 to $190.00 and gave the company a “market perform” rating in a report on Friday, July 29th. Jefferies Group boosted their price target on shares of Teleflex from $157.00 to $185.00 and gave the company a “hold” rating in a report on Friday, July 29th. Barclays PLC boosted their price target on shares of Teleflex from $183.00 to $185.00 and gave the company an “overweight” rating in a report on Friday, July 29th. Finally, Zacks Investment Research upgraded shares of Teleflex from a “hold” rating to a “buy” rating and set a $192.00 price target for the company in a report on Wednesday, June 29th. Two investment analysts have rated the stock with a hold rating, seven have issued a buy rating and one has given a strong buy rating to the stock. The company has a consensus rating of “Buy” and a consensus price target of $171.33.

Teleflex Company Profile

Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company markets and sells its products to hospitals and healthcare providers, across the world, through a combination of its direct sales force and distributors.

5 Day Chart for NYSE:TFX

Receive News & Stock Ratings for Teleflex Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex Inc. and related stocks with our FREE daily email newsletter.